Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Concentrated exposure and response prevention for children with OCD

Official title: A Single Group Evaluation of Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder

Run by Uppsala University Hospital · NCT06621381 · Data updated 2026-11-12

This study is testing a new week-long treatment for children aged 6-12 with OCD to see if it helps reduce their symptoms and improve their daily lives.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment20 (estimated)
SponsorUppsala University Hospital
Academic / other
Locations1 site (Uppsala, Region Uppsala)
StatusRecruiting
StartedSeptember 11, 2024
Main results expectedDecember 14, 2029
Study endsDecember 14, 2029
Registry record updatedOctober 1, 2024
Trial IDNCT06621381 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6-12 years diagnosed with obsessive-compulsive disorder whose guardians consent to the treatment.

Probably not a fit

Patients or guardians who cannot communicate in Swedish will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the preliminary outcomes of a concentrated exposure and response prevention approach for children aged 6-12 years with obsessive-compulsive disorder (OCD). Conducted at Uppsala University Hospital, the study involves trained therapists delivering treatment in an outpatient setting. Participants will receive psychoeducation in a group format followed by individual exposure and response prevention sessions concentrated over one week. The study aims to assess treatment effects on OCD symptoms, functional impact, family accommodation, and clinician ratings of severity and improvement.

Why it matters

Potential benefit: If successful, this approach could significantly reduce OCD symptoms in children and improve their overall functioning.

How similar studies have gone: Other studies have shown success with exposure and response prevention techniques in treating OCD, indicating that this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient fulfills the diagnostic criteria of obsessive-compulsive disorder
* The patient and the legal guardians have said yes to receiving the concentrated exposure with response prevention - treatment

Exclusion Criteria:

* The patient/legal guardians are unable to communicate in Swedish

Where it's running

  • Uppsala University Hospital
    Uppsala, Region Uppsala, Sweden
    Recruiting

Study contacts

  • Principal investigator: Vendela Zetterqvist, Ph D, Associate Professor — Uppsala University Hospital
  • Study coordinator: Vendela Zetterqvist, Ph D, Associate professor
  • Email: vendela.zetterqvist@uu.se
  • Phone: +46 (0)768107060

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.